Anal Cancer – CMA Clinical Spotlight by Dr. Amrita Singh

This article is valued at one hour of CMA/CPD. Please navigate to the end of the article when you have finished reading it in order to undertake your reflective practice exercises that you can then upload to your CMA/CPD section in your membership portal.

Anal cancer is a type of cancer that develops in the tissues of the anus, which is the opening at the end of the digestive tract through which stool leaves the body. It occurs when abnormal cells in the anal canal begin to grow uncontrollably, forming a tumour (NHS, 2023).

Most cases of anal cancer are classified as squamous cell carcinoma, arising from the lining of the anal canal. Other, less common types include adenocarcinoma and melanoma. The disease is relatively rare compared to other cancers of the digestive system but has been increasing in incidence in recent years (Mayo Clinic, 2018).

A significant proportion of anal cancer cases are associated with infection by the human papillomavirus (HPV), which can cause changes in the cells lining the anus and increase the risk of cancer development (Anal Cancer, 2024).

Symptoms may not be noticeable in the early stages, but as the condition progresses, individuals may experience rectal bleeding, pain, itching, or a lump near the anus. Early detection and appropriate treatment are important for improving outcomes (Cleveland Clinic, n.d.).

Reasons for Under-diagnosis and Delayed Diagnosis

Anal cancer is considered to be under-diagnosed and frequently diagnosed at a late stage. Studies show that over half of anal cancer patients are initially misdiagnosed, and it is common for patients to have symptoms for more than six months before receiving a correct diagnosis

• Symptoms Misattributed to Benign Conditions: The most common symptoms—anal bleeding, pain, and itching—are almost identical to common, benign conditions like haemorrhoids, fissures, or warts. In one study, primary care physicians misdiagnosed anal malignancies as haemorrhoids in 27% of first visits.
• Stigma and Embarrassment: The location of the disease causes significant stigma, leading many patients to delay seeking medical care or to avoid mentioning their symptoms to a doctor, often waiting until symptoms are severe.
• Low Public and Provider Awareness: Because anal cancer is relatively rare, it is often not top-of-mind for general practitioners.
• Lack of Standardized Screening: Unlike cervical or colon cancer, there are no widespread, universal screening recommendations for anal cancer in the general population, although high-risk groups (such as those with HIV) are often monitored.
• Hidden Location: Early-stage cancer, which can be easily treated, can be located inside the anal canal and may not be visible from the outside. A digital rectal exam (DRE) or anoscopy is required to detect these tumours. 

Causes

The development of anal cancer is primarily associated with changes in the DNA of cells lining the anal canal, leading to uncontrolled cell growth. These changes are most commonly linked to viral infection and other contributing risk factors rather than a single direct cause (NHS, 2023).

One of the most significant causes is infection with the human papillomavirus (HPV). Certain high-risk strains of HPV can cause abnormal changes in the cells of the anal canal, which may eventually develop into cancer over time. HPV is transmitted through skin-to-skin contact, including sexual contact (Anal Cancer, 2024).

Long-term infection with HPV can lead to precancerous changes, known as anal intraepithelial neoplasia (AIN), which may progress to cancer if not identified and managed appropriately (National Cancer Institute, 2024).

Other contributing factors include conditions that weaken the immune system. Individuals with immunosuppression, such as those living with HIV or those taking immunosuppressive medications, may have a higher likelihood of developing HPV-related cancers (Mayo Clinic, 2018).

Lifestyle factors such as smoking have also been linked to an increased risk of anal cancer, as they may contribute to cellular damage and reduce the body’s ability to clear infections like HPV (Cleveland Clinic, n.d.).

Signs and symptoms

The signs and symptoms of anal cancer may vary depending on the stage of the disease. In the early stages, symptoms may be mild or mistaken for more common conditions such as haemorrhoids, which can delay diagnosis (NHS, 2023).

One of the most common symptoms is rectal or anal bleeding, which may be noticed during or after passing stool. Individuals may also experience pain or discomfort in the anal area, particularly during bowel movements (Mayo Clinic, 2018).

Another common sign is the presence of a lump or growth near the anus, which may be felt externally or internally. This may be accompanied by itching (pruritus) or a persistent sensation of irritation in the anal region (Cleveland Clinic, n.d.).

Changes in bowel habits may also occur, including narrowing of stools, constipation, or a feeling of incomplete bowel emptying. Some individuals may notice unusual discharge from the anus (National Cancer Institute, 2024).

In more advanced stages, symptoms may include swollen lymph nodes in the groin or anal area, increasing pain, and more pronounced changes in bowel function (Anal Cancer, 2024).

Because these symptoms can overlap with less serious conditions, it is important to seek medical evaluation if symptoms are persistent, worsening, or unexplained.

Types

Anal cancer can be classified into different types based on the type of cells in which the cancer develops. The majority of cases fall into one main category, with several less common types also recognised (NHS, 2023).

1. Squamous cell carcinoma
This is the most common type of anal cancer, accounting for the majority of cases. It develops in the flat (squamous) cells that line the anal canal. This type is strongly associated with human papillomavirus (HPV) infection (Mayo Clinic, 2018).

2. Adenocarcinoma
Adenocarcinoma is a less common type that develops in the glandular cells around the anus, which are responsible for producing mucus. This type may behave differently from squamous cell carcinoma and may require different management approaches (Cleveland Clinic, n.d.).

3. Basal cell carcinoma
This is a rare type of anal cancer that arises from basal cells in the skin surrounding the anus. It is more commonly associated with skin cancers in other parts of the body but can occasionally occur in the anal region (National Cancer Institute, 2024).

4. Melanoma
Anal melanoma is a very rare but aggressive form of cancer that develops from pigment-producing cells (melanocytes). It tends to grow and spread more quickly than other types of anal cancer (Anal Cancer, 2024).

Understanding the type of anal cancer is important, as it helps guide treatment decisions and prognosis.

Risk factors

Several factors can increase the likelihood of developing anal cancer, particularly those related to viral infection, immune status, and lifestyle. These risk factors contribute to changes in the cells of the anal canal that may lead to cancer over time (NHS, 2023).

One of the most significant risk factors is infection with the human papillomavirus (HPV), especially high-risk strains. Persistent HPV infection can lead to abnormal cellular changes that increase the risk of cancer development (Anal Cancer, 2024).

Individuals with a weakened immune system are at higher risk. This includes people living with HIV or those taking immunosuppressive medications, as their bodies may be less able to clear infections such as HPV (Mayo Clinic, 2018).

Smoking is another important risk factor, as it can damage cells and impair the immune system’s ability to respond to infections, thereby increasing cancer risk (Cleveland Clinic, n.d.).

A history of anal or cervical cancer, or precancerous conditions such as anal intraepithelial neoplasia (AIN), may also increase the likelihood of developing anal cancer (National Cancer Institute, 2024).

Other contributing factors include multiple sexual partners and engaging in receptive anal intercourse, which may increase the risk of HPV exposure (Anal Cancer, 2024).

Age is also a factor, with anal cancer being more commonly diagnosed in older adults, although it can occur at any age (NHS, 2023).

Complications

Anal cancer can lead to a range of complications, particularly if the disease progresses or spreads beyond the original site. These complications may affect both local tissues and overall health (NHS, 2023).

One of the primary complications is local tissue damage. As the tumour grows, it can invade nearby structures, leading to persistent pain, ulceration, and bleeding in the anal region. This may significantly affect comfort and quality of life (Mayo Clinic, 2018).

Anal cancer may also cause bowel-related complications, such as difficulty passing stool, narrowing of the anal canal, or a feeling of incomplete bowel emptying. In advanced cases, obstruction of the bowel may occur (Cleveland Clinic, n.d.).

Another important complication is the spread of cancer to nearby lymph nodes, particularly in the groin area, leading to swelling and discomfort. If the cancer spreads further (metastasises), it may affect other organs such as the liver or lungs (Anal Cancer, 2024).

Treatment-related complications can also occur. Therapies such as radiation and chemotherapy may lead to skin irritation, fatigue, digestive disturbances, and changes in bowel habits (National Cancer Institute, 2024).

In some cases, individuals may experience psychological distress, including anxiety or emotional difficulty, due to the diagnosis and its impact on daily life (NHS, 2023).

Prognosis

The prognosis of anal cancer depends on several factors, including the stage of the cancer at diagnosis, the type of tumour, overall health, and response to treatment. In general, anal cancer has a relatively favourable prognosis, particularly when detected early and treated appropriately (NHS, 2023).

When diagnosed at an early stage, where the cancer is confined to the anal canal and has not spread, treatment outcomes are often good. Many individuals respond well to combined treatments such as chemotherapy and radiotherapy, which can effectively control or eliminate the cancer (Mayo Clinic, 2018).

If the cancer has spread to nearby lymph nodes or distant organs, the prognosis becomes more variable. Advanced stages may require more intensive treatment and are associated with a lower likelihood of complete recovery, although management can still improve quality of life and control disease progression (Anal Cancer, 2024).

Regular follow-up and monitoring after treatment are important to detect any recurrence and manage ongoing health needs. Early intervention and adherence to treatment plans can significantly influence outcomes (Cleveland Clinic, n.d.).

Nutritional perspective

Nutrition plays an important role in supporting overall health, immune function, and recovery in individuals with anal cancer. While dietary measures do not treat the cancer itself, maintaining a balanced and adequate nutritional intake can help support the body during treatment and recovery (NHS, 2023).

A diet rich in fruits, vegetables, whole grains, and lean proteins provides essential nutrients, vitamins, and antioxidants that support general wellbeing and help the body cope with the physical demands of illness and treatment (Mayo Clinic, 2018).

Adequate protein intake is particularly important, as it supports tissue repair, immune function, and recovery from treatments such as chemotherapy and radiotherapy. Foods such as legumes, dairy, eggs, fish, and lean meats may be included as appropriate (Cleveland Clinic, n.d.).

Some individuals undergoing treatment may experience digestive side effects, such as diarrhoea, discomfort, or changes in bowel habits. In such cases, dietary adjustments—such as choosing easily digestible foods, maintaining hydration, and modifying fibre intake—may help manage symptoms and improve comfort (National Cancer Institute, 2024).

Maintaining adequate hydration is also essential, particularly if there are changes in bowel function or fluid loss. Small, frequent meals may be beneficial for individuals who experience reduced appetite or fatigue during treatment (NHS, 2023).

Psychological perspective

A diagnosis of anal cancer can have a significant psychological and emotional impact, affecting both the individual and their support network. Feelings such as anxiety, fear, uncertainty, and emotional distress are common, particularly following diagnosis and during treatment (NHS, 2023).

The location and nature of the condition may also contribute to feelings of embarrassment, stigma, or reluctance to discuss symptoms, which can affect help-seeking behaviour and emotional wellbeing. Concerns related to body image, privacy, and changes in bodily function may further influence psychological health (Cleveland Clinic, n.d.).

Treatment processes, including chemotherapy and radiotherapy, may be physically demanding and can lead to fatigue, discomfort, and changes in daily routine, which may contribute to low mood, irritability, or reduced motivation (Mayo Clinic, 2018).

Individuals may also experience stress related to uncertainty about prognosis, treatment outcomes, and the potential impact on personal and social life. These concerns can affect coping ability and overall quality of life (Anal Cancer, 2024).

Providing psychological support through clear communication, emotional support, counselling, and access to support networks can help individuals manage these challenges. Encouraging open discussion and reducing stigma are important in promoting emotional wellbeing and helping individuals feel supported throughout their care.

Homeopathic perspective

From a homeopathic perspective, anal cancer is approached as a condition reflecting a disturbance in the body’s overall balance and vitality, affecting both physical and emotional aspects of health. Homeopathy considers not only the local pathology but also the individual’s constitution, symptom expression, and overall wellbeing.

In homeopathic practice, care is highly individualised, with attention given to the person’s unique presentation. This may include physical symptoms such as pain, bleeding, or discomfort, as well as associated factors such as energy levels, emotional responses, sleep patterns, and general health tendencies. Each individual’s experience is considered distinct, guiding the selection of supportive measures.

The homeopathic approach places emphasis on supporting the body’s natural regulatory processes and promoting balance within the system. Attention may also be given to lifestyle factors, emotional wellbeing, and the individual’s response to illness and treatment.

Care may focus on enhancing comfort, resilience, and overall quality of life, particularly in the context of long-term health challenges. Supportive measures may also consider the emotional and psychological aspects associated with diagnosis and treatment, recognising the importance of holistic care.

Within this framework, the aim is to support the individual as a whole, taking into account physical symptoms, emotional state, and environmental influences, with a focus on maintaining wellbeing throughout the course of the condition.

Summary

Anal cancer is a relatively rare malignancy that develops in the anal canal, most commonly arising from squamous cells. It is strongly associated with human papillomavirus (HPV) infection, along with other contributing factors such as immune status, lifestyle influences, and environmental exposure.

Symptoms may include rectal bleeding, pain, itching, or a lump near the anus, although early signs can be subtle and easily mistaken for less serious conditions. Early detection is important, as outcomes are generally more favourable when the disease is diagnosed and treated at an early stage.

The condition can progress and lead to complications such as local tissue damage, spread to lymph nodes, and systemic effects, particularly if left untreated. Prognosis depends on factors such as the stage of disease and response to treatment, with many individuals responding well to appropriate therapies.

A comprehensive approach to care includes attention to nutritional support, psychological wellbeing, and overall health, alongside medical management. Holistic perspectives may support comfort, resilience, and quality of life.

Understanding the causes, symptoms, and progression of anal cancer is essential for promoting early recognition, effective management, and improved outcomes.

---

CMA Reflective Practice

Article: Anal Cancer – CMA Clinical Spotlight
Estimated CPD Time: 1 hour

Reflecting on this article, consider how your current knowledge and clinical awareness align with the key themes presented. Anal cancer, while relatively rare, may present with symptoms that are easily mistaken for more common conditions, highlighting the importance of vigilance in practice.

Reflective Questions:

• How confident are you in recognising early warning signs that may indicate a more serious underlying condition rather than a benign issue?
• In what ways can you support clients in seeking appropriate medical evaluation when symptoms are persistent, unusual, or worsening?
• How might your approach to client education evolve to include greater awareness of risk factors such as HPV, lifestyle influences, and immune health?
• To what extent do you currently integrate nutritional, emotional, and lifestyle support when working with clients facing complex or chronic conditions?
• How can you ensure your communication remains sensitive and supportive when addressing potentially distressing or stigmatised health concerns?

Action Points:

• Identify one area where you can enhance your clinical awareness or referral pathways.
• Consider how you will incorporate a more holistic support strategy into your practice where appropriate.
• Reflect on any additional training or CPD that may strengthen your ability to support clients with complex health presentations.

CPD Logging Guidance:
Please record your reflections, key learning points, and any actions taken as part of your CPD portfolio within the Member Portal.

---

References

Anal Cancer. (2024). Fascrs.org. https://fascrs.org/Web/Web/Patients/Diseases-and-Conditions/A-Z/Anal-Cancer.aspx

Anal Dysplasia & Cancer: Symptoms, Signs, Causes & Treatment. (n.d.). Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/6151-anal-cancer

Mayo Clinic. (2018). Anal cancer – symptoms and causes. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/anal-cancer/symptoms-causes/syc-20354140

National Health Service. (2023). Anal cancer. NHS. https://www.nhs.uk/conditions/anal-cancer/

National Cancer Institute. (2024). Anal cancer treatment (PDQ®)–Patient version. National Institutes of Health. https://www.cancer.gov/types/anal/patient/anal-treatment-pdq

Please do take a look at The Complementary Medical Association “Learn” tab, where you can access our vast repository of evidence-based articles on conditions, therapies, and remedies, and much more.

About the Author

Amrita Singh is a qualified Homoeopath, Psychologist, and Nutritionist with a strong multidisciplinary foundation in mind–body health. She holds an MSc in Psychology (UK) and an MSc in Food, Nutrition & Dietetics (India), alongside formal training in classical homoeopathy from the Central College of Homoeopathy, London. She is currently pursuing postgraduate studies with the Irish School of Homoeopathy.

A full member of the Complementary Medical Association (MCMA), Homoeopathy International (R. Hom. Int.), the British Psychological Society (Graduate Member), and Balen’s insured, Amrita integrates emotional insight, nutritional balance, and gentle homoeopathic care in her clinical approach.

Formerly the Head of Department at RMCH&RC, she now works with clients internationally & runs two physical clinics (Meerut City, Uttar Pradesh & Ambala Cantt., Haryana) in India, offering compassionate, holistic guidance that honours the interconnectedness of emotional wellbeing, physical health, and lifestyle patterns.

Contact & Credentials

Amrita Singh
Homoeopath, Psychologist & Nutritionist
Dip. CCH (England) | MSc Psychology (England) | MSc Food, Nutrition & Dietetics (India)
MCMA | R. Hom. Int. (Balen’s Insured) | GMBPsS

📧 [email protected]
🌐 https://amritasingh.co.uk/
📍 United Kingdom

Instagram – https://www.instagram.com/clinic_uk_2025/

Facebook – https://www.facebook.com/profile.php?id=61582871564526